Scientific and Medical Advisory Council

The Scientific and Medical Advisory Council (SMAC) provides the collective voice and leadership for the Crohn’s and Colitis Canada IBD Research Institute (IBDRI). 

Crohn’s and Colitis Canada relies on guidance from this group of experts as it strives to deliver on its mission to find the cures for Crohn's disease and ulcerative coitis and improve the lives of children and adults affected by these diseases.

The 2017/2018 SMAC includes:

  Members   Institution
  Dr. Mark Silverberg, Chair    University of Toronto, Mount Sinai Hospital
  Dr. John Rioux, Vice-Chair    Université de Montréal & Montreal Heart Institute
  Dr. Laura Sly   University of British Columbia, BC Children's Hospital
  Dr. Tony Otley   Dalhousie University
  Dr. John Marshall   McMaster University Medical Centre
  Dr. Gil Kaplan   Insitute of Public Health, University of Calgary
  Dr. Nicola Jones   University of Toronto, The Hospital for Sick Children
  Dr. Eric Benchimol   University of Ottawa, Children's Hospital of Eastern Ontario
  Dr. Brian Bressler   University of British Columbia, St. Paul's Hospital 

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 150 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest